AMAM - Ambrx Biopharma . American Depositary Shares - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AMAM is currently covered by 6 analysts with an average price target of $34.2. This is a potential upside of $6.2 (22.14%) from yesterday's end of day stock price of $28.

Ambrx Biopharma . American Depositary Shares's activity chart (see below) currently has 2 price targets and 23 ratings on display. The stock rating distribution of AMAM is 76.19% BUY and 23.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 101 days.

Highest price target for AMAM is $32, Lowest price target is $9, average price target is $34.2.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 16-Jan-2024. First documented stock forecast 28-Feb-2022.

Best performing analysts who are covering AMAM - Ambrx Biopharma . American Depositary Shares:

Louise Chen Joel Beatty Yuan Zhi Reni Benjamin Corinne Jenkins Brian Abrahams

Currently out of the existing stock ratings of AMAM, 16 are a BUY (76.19%), 5 are a HOLD (23.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

22

$-6 (-21.43%)

22

5 months 29 days ago

5/6 (83.33%)

$-5.68 (-20.52%)

113

Hold

15

6 months 5 days ago

3/3 (100%)

$3.28 (27.99%)

65

Hold

28

26

6 months 6 days ago

2/2 (100%)

$0.45 (1.63%)

105

Hold

9

$-19 (-67.86%)

10

8 months ago

2/3 (66.67%)

$-0.45 (-4.76%)

181

Buy

32

$4 (14.29%)

33

8 months 1 days ago

0/3 (0%)

$22.99 (255.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AMAM (Ambrx Biopharma . American Depositary Shares) average time for price targets to be met?

On average it took 101 days on average for the stock forecasts to be realized with a an average price target met ratio 75

Which analyst has the current highest performing score on AMAM (Ambrx Biopharma . American Depositary Shares) with a proven track record?

LOUISE CHEN

Which analyst has the current lower performing score on AMAM (Ambrx Biopharma . American Depositary Shares) with a proven track record?

BRIAN ABRAHAMS

Which analyst has the most public recommendations on AMAM (Ambrx Biopharma . American Depositary Shares)?

Louise Chen works at CANTOR FITZGERALD and has 29 price targets and 18 ratings on AMAM

Which analyst is the currently most bullish on AMAM (Ambrx Biopharma . American Depositary Shares)?

Brian Abrahams with highest potential upside - $4

Which analyst is the currently most reserved on AMAM (Ambrx Biopharma . American Depositary Shares)?

Corinne Jenkins with lowest potential downside - -$19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?